Key Points Earnings per share (Non-GAAP) were $0.94 in Q2 2025 beating the analyst estimate by 9.3% (non-GAAP) and the company exceeded its non-GAAP EPS outlook by $0.08. Net sales (GAAP) reached ...

XPO beat estimates on the top and bottom lines in its second-quarter report. After an earlier investment cycle, management ...

Q2 2025 Earnings Call Transcript August 1, 2025 Enbridge Inc. beats earnings expectations. Reported EPS is $0.47, ...

Facing $1 billion in added tariff costs, Procter & Gamble plans to raise prices and lean on cost cuts, but its 70-year ...

Reddit crushed Q2 with soaring revenue, AI monetization, and user growth, but lofty valuation limits upside. Find out why ...

If any investor has stood the test of time, it’s Warren Buffett, and with good reason. For years, the “Oracle of Omaha” has ...

By Chioma Obinna Fidson Healthcare Plc, Nigeria’s leading pharmaceutical manufacturer, has announced the retirement of its ...

Social Islami Bank (SIBL) reported a consolidated loss of Tk321 crore for the April-June quarter of 2025, primarily due to a sharp decline in interest income amid a rise in non-performing loans (NPLs) ...

The company’s share price has surged 11% since early July, reaching Tk229.80. As a result, Square Pharma’s market cap rose by Tk1,959 crore to Tk20,370 crore, making it the second-highest valued firm ...

Warren Buffett's company reported less than half as much profit in the second quarter as it took a $3.76 billion writedown on ...

Sixth Street Specialty trades at a 42% NAV premium with strong coverage and stable earnings, but upside is limited at current ...

Ark Invest analysts say Tesla could be an $8.3 trillion company by 2029, and other Wall Street experts have also made ...